Effect of Muvalaplin on the reduction of major adverse cardiovascular events in adults with elevated Lipoprotein(a), who have had a prior atherosclerotic cardiovascular event, or are at risk for a first atherosclerotic cardiovascular event.

• Pre-screening
• Screening visit
• Oral tablet taken daily